1. In the tube on the right, the gel is not between the cells and plasma. This is a random error that occurs with unknown frequency. 2. The purported culprit is insufficient centrifugal force. It is unclear why it occurs when the correct centrifugal force is used. 3. The results (i.e., for glucose, creatinine, CO 2 , calcium, urea, sodium, potassium, chloride, protein, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, bilirubin, magnesium, phosphorus, iron, and transferrin) were the same as those for a paired tube that had the expected gel migration and no thrombin. Such samples can be used, but they should be treated as unseparated samples and either used or separated immediately. Acknowledgments: BD provided the thrombin-containing bloodcollection tubes.
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Too Many Roads Not Taken in Biomarker Discovery: The Story of Missing Tools
Sean A. Agger * The draft sequence of the human genome was completed in 2000, and scientists, funding agencies, and industry all claimed at the time that this groundbreaking accomplishment would translate into benefits for modern medicine by identifying "druggable" protein targets. Surprisingly, today a majority of the research remains focused on a small number of proteins that were identified before the sequencing of the human genome. The fact that protein research has not changed despite the "genomic revolution" highlights 3 important questions. First, has the Human Genome Project produced the "fruits" we thought it would? Second, why do scientists continue to study the same proteins that were identified in the pre-human genome era? Finally, how can we encourage the study of the novel proteins that have been revealed as a result of the Human Genome Project? These questions and some potential solutions are discussed by Edwards et al. in the commentary "Too Many Roads Not Taken" (1 ). These authors focused on research surrounding kinases, nuclear receptors, and ion channels, all of which are major contributors in the development of disease and are key targets for drugdiscovery programs. In a bibliometric analysis, Edwards et al. discovered a consistent pattern of research activity in these protein families over the past 20 years suggesting that the newly available genomic data have not substantially influenced biomedical investigation. Surprisingly, 50 of the protein kinases that were most commonly referenced before creation of the genome draft still make up an overwhelming number of the citations in the postgenomic era. This observation holds true although Ͼ500 kinases have now been an-
